![Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications | Signal Transduction and Targeted Therapy Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-020-00300-w/MediaObjects/41392_2020_300_Fig1_HTML.png)
Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications | Signal Transduction and Targeted Therapy
![Cells | Free Full-Text | Transcriptional Regulation during Aberrant Activation of NF-κB Signalling in Cancer Cells | Free Full-Text | Transcriptional Regulation during Aberrant Activation of NF-κB Signalling in Cancer](https://www.mdpi.com/cells/cells-12-00788/article_deploy/html/images/cells-12-00788-g001.png)
Cells | Free Full-Text | Transcriptional Regulation during Aberrant Activation of NF-κB Signalling in Cancer
![Antioxidants | Free Full-Text | Honey: A Promising Therapeutic Supplement for the Prevention and Management of Osteoporosis and Breast Cancer Antioxidants | Free Full-Text | Honey: A Promising Therapeutic Supplement for the Prevention and Management of Osteoporosis and Breast Cancer](https://www.mdpi.com/antioxidants/antioxidants-12-00567/article_deploy/html/images/antioxidants-12-00567-g001.png)
Antioxidants | Free Full-Text | Honey: A Promising Therapeutic Supplement for the Prevention and Management of Osteoporosis and Breast Cancer
![IJMS | Free Full-Text | Receptor Activator of Nuclear Factor Kappa B (RANK) and Clinicopathological Variables in Endometrial Cancer: A Study at Protein and Gene Level IJMS | Free Full-Text | Receptor Activator of Nuclear Factor Kappa B (RANK) and Clinicopathological Variables in Endometrial Cancer: A Study at Protein and Gene Level](https://www.mdpi.com/ijms/ijms-19-01848/article_deploy/html/images/ijms-19-01848-g001.png)
IJMS | Free Full-Text | Receptor Activator of Nuclear Factor Kappa B (RANK) and Clinicopathological Variables in Endometrial Cancer: A Study at Protein and Gene Level
![PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer: Molecular Therapy - Oncolytics PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/0a7d4171-24ae-434f-bbc8-632bb35523f5/fx1_lrg.jpg)
PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer: Molecular Therapy - Oncolytics
![Frontiers | Simultaneous Presentation of Multiple Myeloma and Lung Cancer: Case Report and Gene Bioinformatics Analysis Frontiers | Simultaneous Presentation of Multiple Myeloma and Lung Cancer: Case Report and Gene Bioinformatics Analysis](https://www.frontiersin.org/files/Articles/859735/fonc-12-859735-HTML-r1/image_m/fonc-12-859735-g001.jpg)
Frontiers | Simultaneous Presentation of Multiple Myeloma and Lung Cancer: Case Report and Gene Bioinformatics Analysis
![Systems pharmacology to reveal multi-scale mechanisms of traditional Chinese medicine for gastric cancer | Scientific Reports Systems pharmacology to reveal multi-scale mechanisms of traditional Chinese medicine for gastric cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-01535-5/MediaObjects/41598_2021_1535_Fig1_HTML.png)
Systems pharmacology to reveal multi-scale mechanisms of traditional Chinese medicine for gastric cancer | Scientific Reports
![Frontiers | Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches Frontiers | Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches](https://www.frontiersin.org/files/Articles/891652/fonc-12-891652-HTML/image_m/fonc-12-891652-g001.jpg)